Pharma Reviews: Glenmark Life Sciences IPO: Company Aims to Raise Funds Amidst a Pharma Sell-Off

Since FY 2018, the Indian API market has grown at a steady rate of 9.2%, and it is expected to continue to grow as the global pharmaceutical industry ...
Read more: Glenmark Life Sciences IPO: Company Aims to Raise Funds Amidst a Pharma Sell-Off